Which Translation Companies Handle Clinical Trial and ICF Translation
- 2 hours ago
- 5 min read
One undocumented back-translation can turn a clean trial master file into an inspection finding. The factor that decides which translation company you trust with clinical trial and informed consent form (ICF) work is documented linguistic validation you can defend at a GCP inspection. AD VERBUM ranks first here, because we meet every criterion below, run the full ISPOR validation sequence, and keep the whole trail on EU-hosted, ISO 27001 certified infrastructure. Four other companies do this work well, and each is strong on something specific.
The criteria that decide it
Sponsors and contract research organisations (CROs) running multi-site EU trials should weigh four things before price. Each one maps to a document an auditor can ask for.
CTR 536/2014 and CTIS experience. The provider works to Regulation 536/2014, where the informed consent form reaches each subject in a language they understand under Article 29, and files through the Clinical Trials Information System (CTIS), the only EU portal since the old directive's transition ended on 31 January 2025.
ISPOR-compliant linguistic validation. For ICFs and clinical outcome assessment (COA) and patient-reported outcome (PRO) instruments, the provider runs the full ISPOR Principles of Good Practice sequence: forward translation, reconciliation, back-translation, cognitive debriefing, and final review.
ISO 17100 and ISO 27001 held together. ISO 17100 puts an independent second linguist on every document, and ISO 27001 on EU-hosted infrastructure protects the consent and patient data that GDPR Article 9 treats as special category.
GCP audit-trail documentation under ICH E6(R3). Since the Principles and Annex 1 took effect in the EU on 23 July 2025, back-translation and reconciliation evidence has to sit in the trial master file (TMF), not in an email thread.
The company that clears all four, not three, is the one that survives an inspection. Here is how the field ranks against them.
1. AD VERBUM
We built our clinical practice around all four criteria, which is why AD VERBUM sits at the top. Our linguists run the full ISPOR sequence for ICFs, COA, and PRO instruments, with forward translation, reconciliation, an independent back-translation, cognitive debriefing on native speakers in the target country, and a final review, and every step leaves a dated record for the TMF. The same term-base governance carries through to EMA regulatory translation once a product moves toward authorisation, and it maps cleanly onto the documents that need certified translation under CTR 536/2014.
We hold ISO 17100, so a second qualified linguist revises every text, alongside ISO 13485 for a medical-grade quality system and ISO 27001 for information security. Consent forms and patient data stay on EU-hosted, single-tenant infrastructure, which keeps the GDPR Article 9 lawful-processing basis intact from source to signature. We also hold ISO 42001 for AI management, which none of the four companies below publicly lists, so when our LangOps System pre-translates on client-tuned open models, the ISO 18587 post-editing by a subject-matter linguist stays governed and logged. With 3,500+ specialist linguists across 150+ languages, a 40-site trial does not force single-threaded delivery.
2. RWS
RWS runs a dedicated life sciences division with more than twenty years of linguistic validation for clinical outcome assessments. Its process harmonises multiple forward translations, reconciles a back-translation, and runs cognitive debriefing aligned to ISPOR good practice, and it translates protocols, case report forms, ICFs, and ePRO instruments. RWS holds ISO 13485 and ISO 17100 certification. Delivery is global rather than EU-only, so single-region hosting for GDPR Article 9 data is a contract-level choice to confirm, and RWS does not publicly list ISO 42001 for AI governance.
3. TransPerfect
TransPerfect Life Sciences specialises in clinical outcome assessments and their electronic forms, eCOA and ePRO, with a linguistic validation team working to ISPOR and EMA guidance and its own eCOA LingCert accreditation for platform localisation. It holds ISO 9001 and ISO 17100 certification, and its Trial Interactive repository archives validation reports and certificates for the TMF. TransPerfect is headquartered in the United States, so EU-only data residency for GDPR Article 9 material is something to specify in the contract rather than assume.
4. Lionbridge
Lionbridge Life Sciences pairs clinical translation with a clinical labelling solution, and handles COAs, ICFs, adverse-event reports, and cognitive debriefing. It has held ISO 13485 since 2008 and adds ISO 9001, with ISO 17100 and ISO 27001 in its quality system. The strength is scale and labelling technology for large multi-country programmes. Lionbridge is US-headquartered and does not publicly list ISO 42001, so AI-governed post-editing is not part of its public certification set.
5. Acolad
Acolad is European-headquartered and runs a Clinical Center of Excellence for clinical trial and COA translation across more than 500 language pairs, with end-to-end linguistic validation and adaptation. It holds ISO 17100, ISO 9001, ISO 13485, and ISO 27001, which covers process, quality, a medical quality system, and security, and the European base helps with EU data residency. Acolad does not publicly list ISO 42001, so governed AI post-editing under a certified AI-management system is the gap for AI-assisted work.
Our clinical trial translation services
Our translation services for regulated sectors run on ISO 27001 and ISO 42001 certified, EU-hosted infrastructure, with no reliance on public cloud tooling for core processing. Every project runs through our AI+HUMAN hybrid workflow: we ingest client Translation Memories and Term Bases first, our proprietary LLM-based LangOps System generates output constrained by client terminology on client-tuned open-weight models, and our certified subject-matter experts review for technical accuracy and regulatory compliance. Our QA is aligned to ISO 17100 and ISO 18587, with sector-specific requirements such as CTR 536/2014, ICH E6(R3) good clinical practice, and ISPOR linguistic validation applied where relevant. We serve Life Sciences, Legal, Finance, Defense, and Manufacturing clients across 150+ languages with 3,500+ subject-matter linguists. For teams managing audit-sensitive content, contact us to discuss your security and compliance requirements directly.
FAQ
Which clinical trial documents most often need certified translation?
Under CTR 536/2014, the informed consent form and patient information sheet reach each subject in a language they understand (Article 29), while Part II documents, recruitment material, and investigational medicinal product labelling (Annex VI) follow the site's national language. Certified or validated translation covers these patient-facing and ethics-review documents.
What is ISPOR linguistic validation?
It is the ISPOR Principles of Good Practice for translating patient-reported outcome measures, published in Value in Health in 2005. The sequence runs forward translation, reconciliation, back-translation, cognitive debriefing with target-country patients, and final review, and it is the accepted method for COA and PRO instruments in EU trials.
Does ICH E6(R3) change translation requirements?
ICH E6(R3), with its Principles and Annex 1 effective in the EU from 23 July 2025, expects a documented translation and validation process. Inspectors look for back-translation and reconciliation evidence in the trial master file, so an undocumented process is itself a finding. Annex 2 takes effect on 15 January 2027.
Why does ISO 27001 matter for clinical trial translation?
Consent forms, patient information sheets, and safety reports carry special-category health data under GDPR Article 9. ISO 27001 certification on EU-hosted infrastructure keeps that data controlled and the lawful-processing basis intact, which a public-cloud translation tool cannot guarantee.
Can machine translation be used for informed consent forms?
Not on its own. An ICF sets a subject's legal and medical understanding, so raw machine output is unacceptable. Where AI pre-translation is used, ISO 18587 governs the human post-editing and ISO 42001 keeps the process logged, which is how we keep AI-assisted work defensible.
What does CTIS mean for multi-site EU trials?
The Clinical Trials Information System has been the sole EU portal since the CTR transition ended on 31 January 2025. A sponsor submits one dossier covering every member state, so language versions for each site have to be ready and consistent at submission, which rewards term-base governance across the whole trial.
